Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean A Regier

Showing results (31-40 of 124) with videos related to

Pageof 13
Sort By:
Journal of Medical Internet Research|December 17, 2024
Heuristics Identified in Health Data-Sharing Preferences of Patients With Cancer: Qualitative Focus Group StudyAnna Hermansen, Samantha Pollard, Kimberlyn McGrail, et al.
Health Economics|November 17, 2021
Utility maximization versus regret minimization in health choice behavior: Evidence from four datasetsJohn Buckell, Vrinda Vasavada, Sarah Wordsworth, et al.
Pharmacoeconomics|September 7, 2019
Demand for Precision Medicine: A Discrete-Choice Experiment and External Validation StudyDean A Regier, David L Veenstra, Anirban Basu, et al.
International Journal of Technology Assessment in Health Care|June 24, 2025
Adopting life-cycle HTA: a tumor-agnostic precision oncology index economic evaluation from publicly available reimbursement reviewsGemma Cupples, Emanuel Krebs, Deirdre Weymann, et al.
Frontiers in Medicine|April 4, 2025
Putting the substance in substantial evidence: an evidence-based approach to flexible drug regulationEmanuel Krebs, Tania Bubela, Melanie McPhail, et al.
The Oncologist|July 13, 2016
Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, CanadaIan Cromwell, Dean A Regier, Stuart J Peacock, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 19, 2018
Valuation of Health and Nonhealth Outcomes from Next-Generation Sequencing: Approaches, Challenges, and SolutionsDean A Regier, Deirdre Weymann, James Buchanan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2016
Preferences for Prostate Cancer Outcomes: A Comparison of the Patient Perspective, the General Population Perspective, and a Population at Risk for Prostate CancerKatharine S Gries, Dean A Regier, Scott D Ramsey, et al.
Pharmacoeconomics|July 27, 2022
Tools for the Economic Evaluation of Precision Medicine: A Scoping Review of Frameworks for Valuing Heterogeneity-Informed DecisionsReka E Pataky, Stirling Bryan, Mohsen Sadatsafavi, et al.
Applied Health Economics and Health Policy|November 9, 2024
Using Genomic Heterogeneity to Inform Therapeutic Decisions for Metastatic Colorectal Cancer: An Application of the Value of Heterogeneity FrameworkReka E Pataky, Stuart Peacock, Stirling Bryan, et al.
Pageof 13

Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Journal of Medical Internet Research|December 17, 2024
Heuristics Identified in Health Data-Sharing Preferences of Patients With Cancer: Qualitative Focus Group StudyAnna Hermansen, Samantha Pollard, Kimberlyn McGrail, et al.
Health Economics|November 17, 2021
Utility maximization versus regret minimization in health choice behavior: Evidence from four datasetsJohn Buckell, Vrinda Vasavada, Sarah Wordsworth, et al.
Pharmacoeconomics|September 7, 2019
Demand for Precision Medicine: A Discrete-Choice Experiment and External Validation StudyDean A Regier, David L Veenstra, Anirban Basu, et al.
International Journal of Technology Assessment in Health Care|June 24, 2025
Adopting life-cycle HTA: a tumor-agnostic precision oncology index economic evaluation from publicly available reimbursement reviewsGemma Cupples, Emanuel Krebs, Deirdre Weymann, et al.
Frontiers in Medicine|April 4, 2025
Putting the substance in substantial evidence: an evidence-based approach to flexible drug regulationEmanuel Krebs, Tania Bubela, Melanie McPhail, et al.
The Oncologist|July 13, 2016
Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, CanadaIan Cromwell, Dean A Regier, Stuart J Peacock, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 19, 2018
Valuation of Health and Nonhealth Outcomes from Next-Generation Sequencing: Approaches, Challenges, and SolutionsDean A Regier, Deirdre Weymann, James Buchanan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2016
Preferences for Prostate Cancer Outcomes: A Comparison of the Patient Perspective, the General Population Perspective, and a Population at Risk for Prostate CancerKatharine S Gries, Dean A Regier, Scott D Ramsey, et al.
Pharmacoeconomics|July 27, 2022
Tools for the Economic Evaluation of Precision Medicine: A Scoping Review of Frameworks for Valuing Heterogeneity-Informed DecisionsReka E Pataky, Stirling Bryan, Mohsen Sadatsafavi, et al.
Applied Health Economics and Health Policy|November 9, 2024
Using Genomic Heterogeneity to Inform Therapeutic Decisions for Metastatic Colorectal Cancer: An Application of the Value of Heterogeneity FrameworkReka E Pataky, Stuart Peacock, Stirling Bryan, et al.
Pageof 13